Learn More
Description
The cobas™ liat CT/NG/MG nucleic acid test is an automated, qualitative in vitro nucleic acid diagnostic test that utilizes real- time polymerase chain reaction (PCR) for the direct detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG) nucleic acid in male urine and vaginal swabs, all in cobas™ PCR Media (Roche Molecular Systems, Inc.). This test is intended as an aid in the diagnosis of urogenital infections in both symptomatic and asymptomatic patients.
Specifications
Specifications
| Content And Storage | 20 tests per kit; store at 2° to 8 °C |
| Clia Complexity | Waived |
| Detectable Analytes | Chlamydia trachomatis, N. gonorrhoeae, Mycoplasma IgG |
| Sensitivity | Chlamydia: male urine (97.3%); vaginal swab (98.2%). Gonorrhea: male urine (100.0%); vaginal swab (97.7%). Mycoplasma Genitalium: male urine (97.1%); vaginal swab (95.2%) |
| Type | PCR test |
| For Use With (Application) | The cobas™ liat CT/NG/MG test is an automated, qualitative in vitro nucleic acid diagnostic using real-time PCR for the detection of CT, NG, and MG in male urine and vaginal swabs. For use with the cobas liat system. |
| Includes | 20 tests per kit; pipettes |
| Quantity | 20 tests per kit |
| Specificity | Chlamydia: male urine (99.9%); vaginal swab (99.8%). Gonorrhea: male urine (99.9%); vaginal swab (99.8%). Mycoplasma Genitalium: male urine (99.2%); vaginal swab (97.8%) |
| Analysis Time | 20 minutes |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.